National Cancer Institute (NCI)
The purpose of this Notice is to correct the Application Types Allowed for PAR-20-053, Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed).
The following sections of PAR-20-053 are being corrected:
Part 2. Full Text of Announcement, Section II. Award Information
Application Types Allowed
Should correctly read (in italics)
All other aspects of the FOA are unchanged.
Please direct all inquiries to: